title: [Results of combined therapy for malignant tumors of the nasal cavity and accessory nasal sinus depending on the fractionation of preoperative radiotherapy].
abstract: Data on the treatment of 215 patients with locally advanced malignancies of the nasal cavity and accessory nasal sinus are presented. All patients received preoperative radiotherapy using different fractionation schemes under a total target dose (TTD) of 32-40 Gy. Surgery was carried out two weeks later. Whenever radicality of surgery was in doubt, postoperative gamma therapy included exposure to 2 Gy 5 times a week (TTD--30-40 Gy) (n=121). Group I (n-57) received radiation at standard fractionated dosage. In group II (n=66), fractionation, tentatively considered "dynamic" was used while, in group III, fractionation was dynamic in actual fact. In group IV (n=10), superfractionation (1+1 Gy) was employed in group V (n=6),--gamma-neutron therapy. Patients in group VI (n=51) were operated on as scheduled and received 5 Gy, twice a week (TTD--20 Gy). According to 5-year follow-up, the best results were obtained with the use of larger doses of preoperative radiation (groups II, III, VI). Postoperative radiotherapy proved ineffective and it would be useless unless ablative procedures were definitely faulty during surgery.
authors.forename: S N
authors.initials: SN
authors.lastname: Vdovina
authors.forename: V G
authors.initials: VG
authors.lastname: Andreev
authors.forename: I A
authors.initials: IA
authors.lastname: Gulibov
authors.forename: V A
authors.initials: VA
authors.lastname: Pankratov
authors.forename: V A
authors.initials: VA
authors.lastname: Rozhnov
authors.forename: V V
authors.initials: VV
authors.lastname: Baryshev
authors.forename: M E
authors.initials: ME
authors.lastname: Buiakova
authors.forename: L V
authors.initials: LV
authors.lastname: Litovkina
mesh_terms: D000328:Adult; D000368:Aged; D019583:Dose Fractionation, Radiation; D005260:Female; D005500:Follow-Up Studies; D005720:Gamma Rays; D006801:Humans; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods*; D009669:Nose Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D010255:Paranasal Sinus Neoplasms / Q000628:therapy; D018714:Radiotherapy, Adjuvant; D017211:Treatment Failure; D016896:Treatment Outcome